Literature DB >> 1952823

Temporal lobectomy in patients with bitemporal epilepsy defined by depth electroencephalography.

L J Hirsch1, S S Spencer, D D Spencer, P D Williamson, R H Mattson.   

Abstract

Patient selection for temporal lobectomy was reviewed for 23 patients with seizures that arose independently from each temporal lobe as detected by depth electroencephalography (EEG). Although neuropsychological testing, interictal EEG findings, imaging studies, and subclinical seizures were also considered, all patients offered temporal lobectomy had (1) at least 50% of the clinical seizures originating from the lobe to be resected, (2) adequate contralateral memory on testing with amobarbital, and (3) no clear evidence of an extratemporal focus. Eleven patients underwent temporal lobectomy. Pathological findings were considered positive in all nine specimens reviewed. Nine patients had no seizures, one had greater than 75% reduction in seizure frequency, and 1 had 50 to 75% reduction. Pathological features and clinical outcome were similar in the 6 patients with fewer than 80% and the 5 patients with at least 80% of seizures originating from the resected lobe. Thus, having fewer than 80% of seizures originate from one temporal lobe should not be an absolute contraindication for temporal lobectomy.

Entities:  

Mesh:

Year:  1991        PMID: 1952823     DOI: 10.1002/ana.410300306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  The Risk-Benefit Ratio for Temporal Lobe Resection in Patients with Bilateral Mesial Temporal Lobe Epilepsy.

Authors:  Lara E Jehi
Journal:  Epilepsy Curr       Date:  2015 Mar-Apr       Impact factor: 7.500

2.  Epilepsy Treatment: A Futurist View.

Authors:  Michael Privitera
Journal:  Epilepsy Curr       Date:  2017 Jul-Aug       Impact factor: 7.500

3.  Ventral hippocampal formation is the primary epileptogenic zone in a rat model of temporal lobe epilepsy.

Authors:  Paul S Buckmaster; Bianca Reyes; Tahsin Kahn; Megan Wyeth
Journal:  J Neurosci       Date:  2022-08-19       Impact factor: 6.709

4.  High frequency oscillations in intracranial EEGs mark epileptogenicity rather than lesion type.

Authors:  Julia Jacobs; Pierre Levan; Claude-Edouard Châtillon; André Olivier; François Dubeau; Jean Gotman
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

5.  Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients.

Authors:  L Jutila; A Immonen; E Mervaala; J Partanen; K Partanen; M Puranen; R Kälviäinen; I Alafuzoff; H Hurskainen; M Vapalahti; A Ylinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

6.  Temporal lobe epilepsy surgery failures: a review.

Authors:  Adil Harroud; Alain Bouthillier; Alexander G Weil; Dang Khoa Nguyen
Journal:  Epilepsy Res Treat       Date:  2012-04-22

7.  Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio?

Authors:  Sharon Chiang; Joline M Fan; Vikram R Rao
Journal:  Epilepsia       Date:  2021-11-01       Impact factor: 6.740

8.  Hippocampal seizure-onset laterality can change over long timescales: A same-patient observation over 500 days.

Authors:  Otis Smart; John D Rolston; Charles M Epstein; Robert E Gross
Journal:  Epilepsy Behav Case Rep       Date:  2013-04-13

9.  Network-Related Changes in Neurotransmitters and Seizure Propagation During Rodent Epileptogenesis.

Authors:  Roni Dhaher; Shaun E Gruenbaum; Mani Ratnesh S Sandhu; Sigrid Ottestad-Hansen; Nathan Tu; Yue Wang; Tih-Shih W Lee; Ketaki Deshpande; Dennis D Spencer; Niels Christian Danbolt; Hitten P Zaveri; Tore Eid
Journal:  Neurology       Date:  2021-03-15       Impact factor: 9.910

10.  DTI-based response-driven modeling of mTLE laterality.

Authors:  Mohammad-Reza Nazem-Zadeh; Kost Elisevich; Ellen L Air; Jason M Schwalb; George Divine; Manpreet Kaur; Vibhangini S Wasade; Fariborz Mahmoudi; Saeed Shokri; Hassan Bagher-Ebadian; Hamid Soltanian-Zadeh
Journal:  Neuroimage Clin       Date:  2015-10-30       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.